CNX THERAPEUTICS
CNX Therapeutics is a pharmaceutical company that aims to commercialize and supply medications specific to CNS disorders.
CNX THERAPEUTICS
Social Links:
Industry:
Biopharma Medical Neuroscience Pharmaceutical
Founded:
1997-01-01
Address:
London, England, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cnx-therapeutics.com
Total Employee:
11+
Status:
Active
Contact:
+44 (0) 20 7821 2840
Current Employees Featured
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-29 | Synchrony Pharma | Synchrony Pharma acquired by CNX Therapeutics | N/A |
Official Site Inspections
http://www.cnx-therapeutics.com
- Host name: 172.67.75.251
- IP address: 172.67.75.251
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "CNX Therapeutics"
About - CNX Therapeutics
John chairs CNX Therapeutics, alongside Advanz Pharma and the fellow Inflexion-backed Rosemont Pharmaceuticals. He started his career as a Medical Rep in 1981 and has since …See details»
CNX Therapeutics - Crunchbase Company Profile
A medication commercialized by CNX Therapeutics for the treatment of CNS disorders, available in specific countries. Panacod: An analgesic medication consisting of paracetamol and codeine, used for opioid-sensitive pain, …See details»
Governance - CNX Therapeutics
Whenever CNX interacts with healthcare professionals, healthcare organisations or patient organisations, we ensure we do so only where we have a legitimate and appropriate business …See details»
About CNX Therapeutics Ltd. - CPHI Online
CNX Therapeutics Ltd. Address LABS House, 15-19 Bloomsbury Way, WC1A 2TH, London, United Kingdom Telephone +44 (0) 20 7821 2840 Website https://www.cnx-therapeutics.com …See details»
CNX Therapeutics Company Profile | Management and Employees …
CNX Therapeutics Profile and History CNX Therapeutics is a speciality pharmaceutical company committed to improving the lives of patients by providing access to essential medicines. They …See details»
CNX Therapeutics - LinkedIn
CNX Therapeutics is a European pharmaceutical company dedicated to improving the lives of patients through the supply of essential medicines. We license and distribute a portfolio of …See details»
CNX THERAPEUTICS LIMITED - Companies House
More for CNX THERAPEUTICS LIMITED (03363032) Registered office address 3 Bunhill Row, London, England, EC1Y 8YZ . Company status Active Company type Private limited Company …See details»
CNX Therapeutics - PitchBook
CNX Therapeutics General Information Description. Operator of the pharmaceutical firm intended to serve the healthcare sector. The company manufactures and distributes a portfolio of specialty brand medicine and …See details»
M&A Spotlight: Quadrupling revenues and expanding ... - Inflexion
CNX Therapeutics is well on its way to being a partner of choice for pharma and biotechs looking to commercialise prescription products in Europe. Inflexion facilitated the carve-out of CNX …See details»
CNX Therapeutics - Contacts, Employees, Board Members
CNX Therapeutics is a pharmaceutical company that aims to commercialize and supply medications specific to CNS disorders.See details»
CNX Therapeutics Ltd. profiles | FinalScout | FinalScout
The goal of CNX Therapeutics is to build a successful European business which will commercialise CNS treatment options and become a specialist in this therapy area. We …See details»
CNX Therapeutics - Overview, News & Similar companies
View CNX Therapeutics (www.cnx-therapeutics.com) location in Greater London, United Kingdom , revenue, industry and description. ... Olga Lund, Chief Financial Officer, has stepped down …See details»
CNX Therapeutics Ireland Limited | Medicines.ie
CNX Therapeutics Ireland Ltd., 5th Floor Rear, Connaught House, 1 Burlington Road, Dublin 4, Dublin, Ireland. Medical Information E-mail: [email protected]; Telephone: +44 …See details»
CNX THERAPEUTICS FRANCE - Societe.com
CNX THERAPEUTICS FRANCE, société par actions simplifiée, au capital social de 1,00 EURO, dont le siège social est situé au 23 RUE D'ANJOU, 75008 PARIS, immatriculée au Registre …See details»
Sustainability - CNX Therapeutics
At CNX, we believe helping people means more than just compliance. It means doing more. Pushing further. Working harder. If every one of us does the right things for the right reasons – …See details»
Klaria signs license agreement for Sumatriptan Alginate film in …
18 hours ago About CNX Therapeutics. CNX Therapeutics is a speciality pharmaceutical company committed to improving the lives of patients by providing access to essential …See details»
Nitrofurantoin CNX Therapeutics 100 mg Prolonged-Release …
Dec 13, 2024 Nitrofurantoin CNX Therapeutics 100mg Prolonged-Release Capsules is a fixed dosage and is therefore not suitable for children under 12 years. Renal impairment. …See details»
Nitrofurantoin CNX Therapeutics 100 mg Prolonged-Release …
Dec 13, 2024 Nitrofurantoin CNX Therapeutics100 mg prolonged-release capsules are 19.4 mm long and 6.9 mm wide capsules with blue opaque cap debossed with “NTRF” in white ink and …See details»
Klaria tecknar licensavtal för Sumatriptan Alginatfilm i Europa med …
18 hours ago Avtalet ger CNX Therapeutics rätt att marknadsföra och sälja Produkten i Europa och Storbritannien under eget varumärke och produktnamn, och parterna planerar en initial …See details»
Value Added Medicines at CNX: Looking ahead to our 2025 launches
Dec 4, 2024 Why VAMs matter to CNX Therapeutics? At CNX, VAMs are at the heart of our strategy, representing more than 50% of our upcoming pipeline. We are committed to …See details»